期刊文献+

慢病毒载体介导半乳凝素-3-shRNA沉默基因对肿瘤细胞的影响 被引量:1

Effects of galectin-3 gene silencing by galectin-3-shRNA mediated with lentiviral vector on tumor cells
下载PDF
导出
摘要 目的:构建干扰半乳凝素-3(Galectin-3)的重组U6慢病毒质粒,体外评价和观察内源性小RNA干扰效果及对细胞增殖和凋亡的影响.方法:根据siRNA设计原则,设计合成短发夹DNA,用于体内转录合成干扰Galectin-3编码序列的发夹RNA.连接,筛选,酶切,鉴定pGCL-GFP/U6 Gal-3shRNA-1;以含无关序列发夹结构的质粒载体为对照,感染乳腺癌细胞系,采用RT-PCR和Western Blot检测mRNA和蛋白表达水平与对照组的差别;MTT法和流式细胞检测其对细胞增殖、凋亡的干扰情况.结果:测序证实重组质粒构建成功,体外试验表明,Galectin-3的mRNA和蛋白表达均一致降低,转染组为(0.028%),阴性对照组为(0.617%),空白对照组为(0.992%),转染组mRNA干扰效率达95%(P<0.05);Galectin-3蛋白表达明显下调,与阴性对照组和空白对照组相比较,差异有统计学意义(P<0.05).MTT检测结果转染组为(0.40±3.69)%,阴性对照组(0.71±0.16)%;转染组和阴性对照组间差异均有统计学意义(P<0.05).细胞凋亡百分率为68.78%.结论:慢病毒介导的Galectin-3-shRNA成功在体外敲减了肿瘤细胞的目的蛋白,影响了肿瘤的发生与发展. AIM: To construct a recombinant lentiviral U6 plasmids of RNA interference (RNAi) of galectin-3 gene, and evaluate and observe the interference vector on cell proliferation and effects of galectin-3-shRNA/U6 apoptosis by endogenous small RNAi in vitro. METHODS: According to the target sequence and design principle of siRNA, the short hairpin DNA was designed and synthesized to interfere with gene Galectin-3. The shDNA duplex was ligated into the recombinant vector pGCL- GFP/U6 plasmid. The positive colonies of pGCL-GFP/U6 Gal-3 shDNA-1 were selected by double restriction enzyme digestion with Hpa I and Xho I. Cell line was transfected with pGCL- GFP/U6 Gal-3 shDNA-1 using pGCL-GFP/U6-scrambled shDNA as control. The expression level of galectin-3 was detected by RT- PCR and Western Blot; then PI-labeled flow cytometric analysis was performed for detecting cell apoptosis, and MTF assay for cell proliferation. RESULTS: The recombinant vector was successfully constructed which was confirmed by sequencing. The in vitro experiment indicated that the expression level of Galectin-3 was down-regulated as Western Blot and RT-PCR analyses demonstrated (P 〈 0.05 vs control group) ;The interfering efficiency of lentiviral vector was 95%. MTT assay showed that the proliferation of MCF- 7 were suppressed to (0.40 ± 3.69) % in transfected group and to (0.71±0. 156)% in control group; the difference between the 2 groups was significant statistically ( P 〈 0. 05 ). FCM assay indicated that lentiviral vector induced cell apoptosis by about 68.78%. CONCLUSION: RNA interference can successfully interfere the expression of galectin-3 in cultured tumor cells and may affect the occurrence and development of the tumor.
出处 《第四军医大学学报》 北大核心 2008年第12期1111-1114,共4页 Journal of the Fourth Military Medical University
基金 河北省科学技术研究与发展课题基金(052761123)
关键词 慢病毒载体 半乳糖凝集素-3 SHRNA 基因沉默 lentiviral vector galectin-3 shRNA gene silencing
  • 相关文献

参考文献12

  • 1Ruebel KH, Jin L, Qian X, et al. Effects of DNA methylation on galectin-3 expression in pituitary tumors[J]. Cancer Res,2005,15,65(4):1136-1140.
  • 2Ramond J, Zimonjic DB, Mignon C, et al. Mapping of the galectin-3 gene to human chromosome 14 at region 14q21-22[J]. Manm genome,1997,8:706-707.
  • 3Califice S, Castronnovo F, Brrule VD. Galectin-3 and cancer[J]. Int J Oncol,2004,25:983-992.
  • 4Ochieng J, Furtak V, Lukyanov P. Extracellular function of galectin-3[J]. Glycoconj J,2004,19:527-535.
  • 5王洪,王明栋,马文斌,杨堤,史彦芳,孔燕国,栗世方,李志红,王任直.半乳凝素-3在侵袭性垂体泌乳素腺瘤中表达[J].中国医学科学院学报,2005,27(3):380-381. 被引量:8
  • 6史彦芳,王明栋,马文斌,杨堤,王洪,王任直,崔全才.垂体催乳素腺瘤中半乳凝素-3-mRNA表达与生物学行为的关系[J].中华神经外科杂志,2007,23(11):857-860. 被引量:3
  • 7Nakahara S, Oka N, Raz A. On the role of Galectin-3 in cancer apoptosis[J]. Apoptosis,2005,10:267-275.
  • 8Paul CP, Good PD, Li SX, et al. Localied expression of small RNA inhibitors in human cell[J]. Mol Ther,2003,7:237-247.
  • 9Manche L, Green SR, Mathews MB. Intreaction between double-stranded RNA regulators and the protein kinase[J]. Dai Mol Cell Biol,1992,12:5238-5248.
  • 10Elbashir SM, Harborth J, Weber K, et al. Analysis of gene function in somatic mammalian cells using small interfering RNAs[J]. Methods,2002,26:191-213.

二级参考文献20

  • 1苏长保,任祖渊,王任直,许志勤,陶蔚,杨义,马文斌,李永宁,连伟,幸兵,杨众.大型和巨大型垂体腺瘤经蝶显微外科治疗的疗效及处理策略[J].中华神经外科杂志,2005,21(3):138-141. 被引量:64
  • 2魏少波,周定标,姜金利,孟祥辉,佟怀宇.经蝶切除垂体腺瘤手术后残留原因分析及再治疗[J].中华神经外科杂志,2005,21(3):153-155. 被引量:8
  • 3王洪,王明栋,马文斌,杨堤,史彦芳,孔燕国,栗世方,李志红,王任直.半乳凝素-3在侵袭性垂体泌乳素腺瘤中表达[J].中国医学科学院学报,2005,27(3):380-381. 被引量:8
  • 4惠国桢,王清,李向东,徐峰,高恒,吴思荣,俞文华,吴智远.经蝶窦显微手术治疗男性泌乳素腺瘤的长期随访分析[J].中华神经外科杂志,2005,21(9):535-538. 被引量:3
  • 5Burger PC, Scheithauer BW, Vogel FS. Surgical pathology of the nervous system and its coverings, New York:CHURCHILL LIVINGSTONE 2002.441-490
  • 6Partridge EA, Le Roy C, Di Guglielmo GM, et ol.Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science, 2004, 306:120-124
  • 7Niedziela M, Maceluch J, Korman E. Galectin-3 is not an universal marker of malignancy in thyroid nodular disease in children and adolescents. J Clin Endocrinol Metab, 2002,87:4411-4415
  • 8Scheithauer BW, Kovacs KT, Laws ER, et al. Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg, 1986, 65:733-744
  • 9Yoshii T, Fukumori T, Honjo Y, et al. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J Biol Chem, 2002, 277:6852-6857
  • 10Mehrotra P, Okpokam A, Bouhaidar R, et al. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Histopathology, 2004, 45:493-500

共引文献7

同被引文献38

  • 1雷彩霞,张炜,孙晓炜,杜国平,王丽,刘银坤.Galectin-3表达抑制对子宫内膜上皮细胞生长周期和黏附性的影响[J].复旦学报(医学版),2007,34(2):169-175. 被引量:12
  • 2程变巧,姜泊,包杰.Galectin-3 shRNA载体的构建表达及其对大肠癌细胞lovo增殖率的影响[J].第四军医大学学报,2007,28(11):1014-1017. 被引量:3
  • 3Dumic J,Dabelic S,Flogel M.Galectins;an open-ended story[J].Biochim Biophys Acta,2006,1760:616-635.
  • 4Yang R Y,Rabinovich G A,Liu F T.Galectins; structure,function and therapeutic potential[J].Expert Rev Mol Med,2008,10:e17.
  • 5Fukumori T,Kanayama H O,Raz A.The roll of galectin-3 in cancer drug resistance[J].Drug Resist Updat,2007,10:101-108.
  • 6李宇华.Galectin-3的亚细胞定位与结肠炎癌变的关系[D].西安:中国人民解放军第四军医大学,2007.
  • 7Takenaka Y,Fukumori T,Ras A.Galectin-3 and metastasis[J].Glycocinj J,2004,19:543-549.
  • 8Nakahara S,Oka N,Raz A.On the role of galectin-3 in cancer apoptosis[J].Apoptosis,2005,10 (2):267-275.
  • 9Krzeslak A,Lipifska A.Galectin-3 as a multifunctional protein[J].Cell Mol Biol Lett,2004,9:305-328.
  • 10Ingrassia L,CambY I,Lefranc F,et al.Anti-galectin compounds as potential anti-cancer drugs[J].Curr Med Chem,2006,13:3513-3527.

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部